Identifying Surrogate Endpoints for DSA Treatment Trials...

Identifying Surrogate Endpoints for DSA Treatment Trials Based on Data from a 10-Year Longitudinal Study of Primary Renal Transplant Recipients.

Everly, M., Rebellato, L., Haisch, C., Dieplinger, G., Briley, K., Bolin, P., Kendrick, W., Kendrick, S., Morgan, C., Hormann, M., Harland, R., Terasaki, P.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
98
Journal:
Transplantation
DOI:
10.1097/00007890-201407151-02336
Date:
July, 2014
File:
PDF, 231 KB
2014
Conversion to is in progress
Conversion to is failed